320 related articles for article (PubMed ID: 30025921)
1. Species specificity of rat and human α7 nicotinic acetylcholine receptors towards different classes of peptide and protein antagonists.
Yu J; Zhu X; Zhang L; Kudryavtsev D; Kasheverov I; Lei Y; Zhangsun D; Tsetlin V; Luo S
Neuropharmacology; 2018 Sep; 139():226-237. PubMed ID: 30025921
[TBL] [Abstract][Full Text] [Related]
2. Key Structural Determinants in the Agonist Binding Loops of Human β2 and β4 Nicotinic Acetylcholine Receptor Subunits Contribute to α3β4 Subtype Selectivity of α-Conotoxins.
Cuny H; Kompella SN; Tae HS; Yu R; Adams DJ
J Biol Chem; 2016 Nov; 291(45):23779-23792. PubMed ID: 27646000
[TBL] [Abstract][Full Text] [Related]
3. α-Conotoxin as Potential to α7-nAChR Recombinant Expressed in
Liu Y; Yin Y; Song Y; Wang K; Wu F; Jiang H
Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32806654
[TBL] [Abstract][Full Text] [Related]
4. Engineered Conotoxin Differentially Blocks and Discriminates Rat and Human α7 Nicotinic Acetylcholine Receptors.
Wang S; Zhu X; Zhangsun M; Wu Y; Yu J; Harvey PJ; Kaas Q; Zhangsun D; Craik DJ; Luo S
J Med Chem; 2021 May; 64(9):5620-5631. PubMed ID: 33902275
[TBL] [Abstract][Full Text] [Related]
5. Alanine scan of α-conotoxin RegIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonist.
Kompella SN; Hung A; Clark RJ; Marí F; Adams DJ
J Biol Chem; 2015 Jan; 290(2):1039-48. PubMed ID: 25411242
[TBL] [Abstract][Full Text] [Related]
6. Effects of C-Terminal Carboxylation on α-Conotoxin LsIA Interactions with Human α7 Nicotinic Acetylcholine Receptor: Molecular Simulation Studies.
Wen J; Hung A
Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 30987002
[TBL] [Abstract][Full Text] [Related]
7. Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors.
Hone AJ; Talley TT; Bobango J; Huidobro Melo C; Hararah F; Gajewiak J; Christensen S; Harvey PJ; Craik DJ; McIntosh JM
J Biol Chem; 2018 Nov; 293(46):17838-17852. PubMed ID: 30249616
[TBL] [Abstract][Full Text] [Related]
8. αO-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human α9α10 subtype.
Zhangsun D; Zhu X; Kaas Q; Wu Y; Craik DJ; McIntosh JM; Luo S
Neuropharmacology; 2017 Dec; 127():243-252. PubMed ID: 28416445
[TBL] [Abstract][Full Text] [Related]
9. Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist.
Whiteaker P; Christensen S; Yoshikami D; Dowell C; Watkins M; Gulyas J; Rivier J; Olivera BM; McIntosh JM
Biochemistry; 2007 Jun; 46(22):6628-38. PubMed ID: 17497892
[TBL] [Abstract][Full Text] [Related]
10. A synthetic combinatorial strategy for developing alpha-conotoxin analogs as potent alpha7 nicotinic acetylcholine receptor antagonists.
Armishaw CJ; Singh N; Medina-Franco JL; Clark RJ; Scott KC; Houghten RA; Jensen AA
J Biol Chem; 2010 Jan; 285(3):1809-21. PubMed ID: 19901032
[TBL] [Abstract][Full Text] [Related]
11. Molecular Basis for Differential Sensitivity of α-Conotoxin RegIIA at Rat and Human Neuronal Nicotinic Acetylcholine Receptors.
Kompella SN; Cuny H; Hung A; Adams DJ
Mol Pharmacol; 2015 Dec; 88(6):993-1001. PubMed ID: 26438212
[TBL] [Abstract][Full Text] [Related]
12. RegIIA: an α4/7-conotoxin from the venom of Conus regius that potently blocks α3β4 nAChRs.
Franco A; Kompella SN; Akondi KB; Melaun C; Daly NL; Luetje CW; Alewood PF; Craik DJ; Adams DJ; Marí F
Biochem Pharmacol; 2012 Feb; 83(3):419-26. PubMed ID: 22108175
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro testing of native α-conotoxins from the injected venom of Conus purpurascens.
Hoggard MF; Rodriguez AM; Cano H; Clark E; Tae HS; Adams DJ; Godenschwege TA; Marí F
Neuropharmacology; 2017 Dec; 127():253-259. PubMed ID: 28917942
[TBL] [Abstract][Full Text] [Related]
14. Dimerization of α-Conotoxins as a Strategy to Enhance the Inhibition of the Human α7 and α9α10 Nicotinic Acetylcholine Receptors.
Liang J; Tae HS; Xu X; Jiang T; Adams DJ; Yu R
J Med Chem; 2020 Mar; 63(6):2974-2985. PubMed ID: 32101438
[TBL] [Abstract][Full Text] [Related]
15. The Allosteric Activation of α7 nAChR by α-Conotoxin MrIC Is Modified by Mutations at the Vestibular Site.
Gulsevin A; Papke RL; Stokes C; Tran HNT; Jin AH; Vetter I; Meiler J
Toxins (Basel); 2021 Aug; 13(8):. PubMed ID: 34437426
[TBL] [Abstract][Full Text] [Related]
16. Rational design of alpha-conotoxin analogues targeting alpha7 nicotinic acetylcholine receptors: improved antagonistic activity by incorporation of proline derivatives.
Armishaw C; Jensen AA; Balle T; Clark RJ; Harpsøe K; Skonberg C; Liljefors T; Strømgaard K
J Biol Chem; 2009 Apr; 284(14):9498-512. PubMed ID: 19131337
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent α-Conotoxin [Q1G, ΔR14]LvIB Identifies the Distribution of
Shan H; Wang N; Gao X; Wang Z; Yu J; Zhangsun D; Zhu X; Luo S
Mar Drugs; 2024 Apr; 22(5):. PubMed ID: 38786593
[No Abstract] [Full Text] [Related]
18. Rational design of new ligands for nicotinic receptors on the basis of α-conotoxin PnIA.
Kasheverov IE; Kudryavtsev DS; Ivanov IA; Zhmak MN; Chugunov AO; Tabakmakher VM; Zelepuga EA; Efremov RG; Tsetlin VI
Dokl Biochem Biophys; 2015; 461():106-9. PubMed ID: 25937226
[No Abstract] [Full Text] [Related]
19. Inhibition of cholinergic pathways in Drosophila melanogaster by α-conotoxins.
Heghinian MD; Mejia M; Adams DJ; Godenschwege TA; Marí F
FASEB J; 2015 Mar; 29(3):1011-8. PubMed ID: 25466886
[TBL] [Abstract][Full Text] [Related]
20. Rational Design of α-Conotoxin RegIIA Analogues Selectively Inhibiting the Human α3β2 Nicotinic Acetylcholine Receptor through Computational Scanning.
Xu Q; Tae HS; Wang Z; Jiang T; Adams DJ; Yu R
ACS Chem Neurosci; 2020 Sep; 11(18):2804-2811. PubMed ID: 32649832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
